Lantheus Holdings Gross Margin 2013-2025 | LNTH
Current and historical gross margin for Lantheus Holdings (LNTH) over the last 10 years. The current gross profit margin for Lantheus Holdings as of June 30, 2025 is %.
| Lantheus Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $1.52B | $0.97B | 63.77% |
| 2025-03-31 | $1.54B | $0.99B | 64.09% |
| 2024-12-31 | $1.53B | $0.99B | 64.47% |
| 2024-09-30 | $1.50B | $0.97B | 64.80% |
| 2024-06-30 | $1.44B | $0.93B | 64.53% |
| 2024-03-31 | $1.37B | $0.88B | 64.06% |
| 2023-12-31 | $1.30B | $0.71B | 54.74% |
| 2023-09-30 | $1.21B | $0.65B | 53.65% |
| 2023-06-30 | $1.13B | $0.59B | 52.80% |
| 2023-03-31 | $1.03B | $0.53B | 51.51% |
| 2022-12-31 | $0.94B | $0.58B | 62.14% |
| 2022-09-30 | $0.80B | $0.47B | 58.85% |
| 2022-06-30 | $0.67B | $0.37B | 55.34% |
| 2022-03-31 | $0.54B | $0.28B | 50.92% |
| 2021-12-31 | $0.43B | $0.19B | 44.13% |
| 2021-09-30 | $0.39B | $0.17B | 43.33% |
| 2021-06-30 | $0.38B | $0.16B | 42.97% |
| 2021-03-31 | $0.34B | $0.14B | 41.52% |
| 2020-12-31 | $0.34B | $0.14B | 40.88% |
| 2020-09-30 | $0.34B | $0.15B | 43.28% |
| 2020-06-30 | $0.33B | $0.15B | 45.48% |
| 2020-03-31 | $0.35B | $0.17B | 48.30% |
| 2019-12-31 | $0.35B | $0.18B | 50.57% |
| 2019-09-30 | $0.35B | $0.18B | 50.72% |
| 2019-06-30 | $0.35B | $0.18B | 51.15% |
| 2019-03-31 | $0.35B | $0.18B | 50.86% |
| 2018-12-31 | $0.34B | $0.18B | 50.87% |
| 2018-09-30 | $0.34B | $0.17B | 49.85% |
| 2018-06-30 | $0.33B | $0.16B | 49.39% |
| 2018-03-31 | $0.33B | $0.17B | 49.55% |
| 2017-12-31 | $0.33B | $0.16B | 49.24% |
| 2017-09-30 | $0.32B | $0.16B | 49.38% |
| 2017-06-30 | $0.32B | $0.16B | 48.90% |
| 2017-03-31 | $0.31B | $0.15B | 47.39% |
| 2016-12-31 | $0.30B | $0.14B | 46.18% |
| 2016-09-30 | $0.30B | $0.14B | 45.97% |
| 2016-06-30 | $0.30B | $0.14B | 45.82% |
| 2016-03-31 | $0.29B | $0.13B | 45.58% |
| 2015-12-31 | $0.29B | $0.14B | 46.42% |
| 2015-06-30 | $0.22B | $0.10B | 45.09% |
| 2015-03-31 | $0.23B | $0.10B | 43.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.806B | $1.534B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |